Report card. HIV prevention for girls and young women: Cambodia
This report card aims to provide a summary of HIV prevention for girls and young women in Cambodia.
This report card aims to provide a summary of HIV prevention for girls and young women in Cambodia.
This report card aims to provide a summary of HIV prevention for girls and young women in China.
This report card aims to provide a summary of HIV prevention for girls and young women in India.
Using available documents from 2000-2006, this publication reviews and summarizes risks and vulnerabilities associated with HIV infection among cross-border migrants working in various labour sectors in Thailand.
This publication describes a successful component of the HIV prevention and control efforts for mobile populations in Can Tho province, The Far Away from Home Club.
The Ethnography Study of Male to Male Sexuality in Cambodia was done taking a life history approach of the interviewees in order to understand their ideas and concepts in terms of homosexual relationships and the contexts in which they occur in Cambodia.
Entrevistas a doce niñas y adolescentes que viven con VIH de diversos países de América Latina. Hablan de su vida, la discriminación, las redes sociales que los apoyan y su sexualidad. En la parte final se incluye una pequeña encuesta que se aplicó a las entrevistadas.
The United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific (UN RTF) commissioned the Centre for Harm Reduction (CHR), Macfarlane Burnet Institute for Medical Research and Public Health, Australia to undertake a baseline assessment of current policies, progr
This protocol has been developed to meet a need for guidance on counseling of children and their parents/guardians about HIV/AIDS in 30 USAID/FHI projects with orphans and vulnerable children (OVC) under the IMPACT project in India.
According to the National AIDS Control Organisation (NACO) India has 5.2 million HIV-positive people and an HIV-prevalence of 0.9 percent of adults - about the same as the global average, or the sero-prevalence in North America, Eastern Europe and Central Asia.